Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate

Annals of Surgery

Volumn 253, Issue 4, 2011, Pages 769-773

  Chua, Terence C ^a   Liauw, Winston ^a   Zhao, Jing ^a   Morris, David L ^a,b  

^a ST GEORGE HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ADULT; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OPERATION DURATION; OVERALL SURVIVAL; PERIOPERATIVE COMPLICATION; PERIOPERATIVE INTRAPERITONEAL CHEMOTHERAPY; PERITONEAL DIALYSIS; PERITONEUM PSEUDOMYXOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFUSIONS, PARENTERAL; KAPLAN-MEIER ESTIMATE; LAPAROTOMY; MALE; MITOMYCINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERIOPERATIVE CARE; PERITONEAL NEOPLASMS; PERITONEUM; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PSEUDOMYXOMA PERITONEI; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79953198905     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31820b4dba     Document Type: Article

References (21)

1. Biggs MH. Pseudomyxoma Peritonei: with report of six cases. Ann Surg. 1920;71(5):619-627.
2. Ronnett BM, Zahn CM, Kurman RJ, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol. 1995;19(12):1390-1408.
3. Brigitte MR, Hui Y, Robert JK, et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer. 2001;92(1):85-91.
4. Bradley RF, Stewart JHt, Russell GB, et al. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol. 2006;30(5): 551-559. (Pubitemid 44265007)
5. Petrus J, Heikki JJ, Anna L. Survival of patients with pseudomyxoma peritonei treated by serial debulking. Colorectal Dis. 2009;9999(999A).
6. Gough DB, Donohue JH, Schutt AJ, et al. Pseudomyxoma peritonei. Longterm patient survival with an aggressive regional approach. Ann Surg. 1994;219(2):112-119. (Pubitemid 24064067)
7. Miner TJ, Shia J, Jaques DP, et al. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg. 2005;241(2):300-308.
8. Yan TD, Bijelic L, Sugarbaker PH. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol. 2007;14(8):2289-2299. (Pubitemid 47174931)
9. Chua TC, Yan TD, Smigielski ME, et al. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution. Ann Surg Oncol. 2009;16(7):1903-1911.
10. Jacquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res. 1996;15: 49-58. (Pubitemid 26130826)
11. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29-42.
12. Murphy EM, Farquharson SM, Moran BJ. Management of an unexpected appendiceal neoplasm. Br J Surg. 2006;93(7):783-792. (Pubitemid 44035249)
13. Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 2006;7:69-76. (Pubitemid 43025395)
14. M̈uller D. Appendiceal neoplasm resulting from a malignant transformation of a villous adenoma. Chirurg. 1980;51(9):609-610.
15. Sugarbaker PH. Are there curative options to peritoneal carcinomatosis? Ann Surg. 2005;242(5):748-750.
16. Yan TD, Black D, Savady R, et al. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol. 2007;14(2):484-492. (Pubitemid 46175292)
17. Cioppa T, Vaira M, Bing C, et al. Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei. World J Gastroenterol. 2008;14(44): 6817-6823.
18. Rout S, Renehan AG, Parkinson MF, et al. Treatments and outcomes of peritoneal surface tumors through a centralized national service (United kingdom). Dis Colon Rectum. 2009;52(10):1705-1714.
19. Elias D, Honoŕe C, Ciuchend́ea R, et al. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg. 2008;95(9):1164-1171.
20. Baratti D, Kusamura S, Nonaka D, et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2008;15(2):526-534.
21. Murphy EM, Sexton R,Moran BJ. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum. 2007;50(1):37-42. (Pubitemid 46147019)